News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Biosciences, Inc. to Present at American Association for Cancer Research 2012 Annual Meeting



3/27/2012 7:11:05 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, that are capable of up to a ten-fold increase in drug concentration at tumor sites, announced today that a poster presentation on its lead drug candidate BIND-014, has been selected for a late-breaking clinical research presentation at the American Association for Cancer Research (AACR) 2012 Annual Meeting taking place March 31-April 4, 2012 in Chicago, IL. In addition, BIND Biosciences will participate in an NCI/NIH sponsored session on materials characterization for cancer treatment and diagnosis.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES